Gitterman Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-366
| Closed | -$385K | – | 144 |
|
|
2024
Q2 | $385K | Buy |
366
+22
| +6% | +$23.1K | 0.15% | 40 |
|
|
2024
Q1 | $331K | Buy |
344
+41
| +14% | +$39.5K | 0.13% | 53 |
|
|
2023
Q4 | $266K | Sell |
303
-94
| -24% | -$82.6K | 0.12% | 59 |
|
|
2023
Q3 | $327K | Buy |
+397
| New | +$327K | 0.16% | 33 |
|
|
2023
Q2 | – | Sell |
-355
| Closed | -$291K | – | 103 |
|
|
2023
Q1 | $291K | Buy |
355
+42
| +13% | +$34.4K | 0.14% | 35 |
|
|
2022
Q4 | $225K | Sell |
313
-76
| -20% | -$54.7K | 0.11% | 60 |
|
|
2022
Q3 | $265K | Buy |
+389
| New | +$265K | 0.27% | 40 |
|
|
2021
Q4 | – | Sell |
-401
| Closed | -$243K | – | 101 |
|
|
2021
Q3 | $243K | Buy |
+401
| New | +$243K | 0.2% | 57 |
|